Moneycontrol

Budget 2021

Associate Partners:

  • SMC
  • Samsung
  • Volvo

Moneycontrol

Budget 2021

Associate Partners:

  • SMCSamsungVolvo
Webinar :Join an expert panel for a webinar on Smart investments for a secure retirement January 28, 2021. Register now!
you are here: HomeNewsBusiness

Coronavirus crisis | Tata Steel's European units may not receive funding from parent: Report

On April 13, Tata Steel's board approved a plan to raise as much as Rs 7,000 crore through non-convertible debentures (NCDs).

April 29, 2020 / 10:35 AM IST

Tata Steel's European businesses may not receive financial support from the parent company and may have to rely on the UK government's help for survival during the COVID-19 pandemic.

Tata Sons might not inject further capital to assist Tata Steel's loss-making UK and other European units, according to a report by The Economic Times.

Tata Sons needs to allocate funds for other financial commitments, officials told the publication.

Follow LIVE updates on the COVID-19 pandemic here

Moneycontrol could not independently verify the story.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Tata Sons declined to comment when approached by The Economic Times.

"European steel demand has sharply reduced compared to normal conditions and many of our customers paused production, including European car manufacturers. We, therefore, reduced production at some of our European mills to match this lower demand. Our European business is focused on preserving cash and liquidity to tide it over during the challenging period," a Tata Steel spokesperson told the publication.

The UK government might provide only one-fifth of the cost required, sources told the paper.

Media reports suggest Tata Steel has sought 500 million pounds (Rs 4,750 crore) from the UK government.

On April 13, Tata Steel's board approved a plan to raise as much as Rs 7,000 crore through non-convertible debentures (NCDs).

Follow our full coverage of the COVID-19 pandemic here.
Moneycontrol News
first published: Apr 29, 2020 10:35 am

stay updated

Get Daily News on your Browser
Sections